Swiss QUality of life and healthcare impact Assessment in a Real-world Erenumab treated migraine population (SQUARE study): interim results - PubMed
Source : https://pubmed.ncbi.nlm.nih.gov/36401172/
doi: 10.1186/s10194-022-01515-8. 1 Department of Neurology and Neurorehabilitation, ZURZACH Care, Bad Zurzach, Switzerland. [email protected]. 2 Kopfwehzentrum Hirslanden, Zurich, Switzerland. 3 Department of Neurology, Inselspital, University Hospital Bern and University of Bern, Bern, Switzerland. 4 Neurocentre, Luzerner Kantonsspital, Lucerne, Switzerland. 5 Center for Pain Medicine, Nottwil, Switzerland. 6 Department of Neurology, Spital Thun, Thun, Switzerland.
Conclusions: Overall quality of life improved and treatment satisfaction was rated high with erenumab treatment in real-world clinical practice. In addition, the reported impact of migraine on spouses and children of patients was reduced."